Health Condition 1: H53- Visual disturbances
Conditions
Interventions
Intervention1: Flora Vision Dry Eyes drops/Spray: It helps to sustain the physiological conditions of the ocular surface and lachrymal system. It brings quick and lasting relief in case of sensation o
Sponsors
NOVAX PHARMA S.A.M.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pediatric subjects (6 to 18 years of age) 2. Subjects who experience eye dryness
Exclusion criteria
Exclusion criteria: 1. Anyone with known allergic reaction to the ingredients of the eye drops/spray 2. Subjects with existing eye infection 3. History of ocular surgery 4. History or active signs of severe or serious ocular conditions such as inflammatory corneal ulcers, recurrent erosions, and uveitis at any time 5. Subjects participating in any another clinical trial during study 6. Subjects without written consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study is to evaluate the safety (observation of complications, side effects or risks affecting vision) of the product from the baseline with follow up visits.Timepoint: There will be 4 follow up visits expected after using the product: 1st Visit Day 7 of product usage 2nd Visit Day 15 of product usage 3rd Visit Day 30 of product usage 4th Visit Day 60 of product usage | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective will be to assess performance (alleviation of eye dryness) of the product.Timepoint: There will be 4 follow up visits expected after using the product: 1st Visit Day 7 of product usage 2nd Visit Day 15 of product usage 3rd Visit Day 30 of product usage 4th Visit Day 60 of product usage | — |
Countries
India
Contacts
Public ContactDr Suresh S
Nalam Homoeo Clinic & Research Center
Outcome results
None listed